Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 13.7
(-1.58%)
CNY 13.7
(-1.58%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 389.05 Million CNY | 311.3% |
| 2022 | 94.58 Million CNY | -53.8% |
| 2021 | 204.73 Million CNY | 46.03% |
| 2020 | 140.19 Million CNY | -71.43% |
| 2019 | 490.69 Million CNY | 3293025426787533000.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 3.28 Million CNY | -93.19% |
| 2015 | 48.33 Million CNY | 383.39% |
| 2014 | 10 Million CNY | -87.34% |
| 2013 | 79 Million CNY | -20.84% |
| 2012 | 99.8 Million CNY | -6.86% |
| 2011 | 107.15 Million CNY | 94.82% |
| 2010 | 55 Million CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 16 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 398.39 Million CNY | 2.4% |
| 2024 Q2 | 420.2 Million CNY | 5.48% |
| 2024 Q3 | 375.95 Million CNY | -10.53% |
| 2023 Q2 | 207.01 Million CNY | 19.12% |
| 2023 FY | 389.05 Million CNY | 311.3% |
| 2023 Q1 | 173.79 Million CNY | 83.73% |
| 2023 Q3 | 310.75 Million CNY | 50.11% |
| 2023 Q4 | 389.05 Million CNY | 25.2% |
| 2022 FY | 94.58 Million CNY | -53.8% |
| 2022 Q4 | 94.58 Million CNY | -62.5% |
| 2022 Q3 | 252.2 Million CNY | 2.97% |
| 2022 Q2 | 244.92 Million CNY | 18.73% |
| 2022 Q1 | 206.28 Million CNY | 0.76% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q4 | 204.73 Million CNY | 15069.53% |
| 2021 Q2 | 1.34 Million CNY | 0.0% |
| 2021 Q3 | 1.34 Million CNY | 0.0% |
| 2021 FY | 204.73 Million CNY | 46.03% |
| 2020 Q2 | 470.39 Million CNY | -4.24% |
| 2020 FY | 140.19 Million CNY | -71.43% |
| 2020 Q3 | 410.52 Million CNY | -12.73% |
| 2020 Q4 | 140.19 Million CNY | -65.85% |
| 2020 Q1 | 491.22 Million CNY | 0.11% |
| 2019 FY | 490.69 Million CNY | 3293025426787533000.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 100.0% |
| 2019 Q4 | 490.69 Million CNY | 3293025426787533000.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2017 Q1 | 3.28 Million CNY | 0.0% |
| 2017 Q2 | - CNY | -100.0% |
| 2016 Q1 | 40.86 Million CNY | -15.46% |
| 2016 Q4 | 3.28 Million CNY | -87.53% |
| 2016 Q3 | 26.37 Million CNY | -21.67% |
| 2016 Q2 | 33.66 Million CNY | -17.61% |
| 2016 FY | 3.28 Million CNY | -93.19% |
| 2015 Q4 | 48.33 Million CNY | 211.86% |
| 2015 Q3 | 15.5 Million CNY | -43.64% |
| 2015 Q2 | 27.5 Million CNY | 175.0% |
| 2015 Q1 | 10 Million CNY | 0.0% |
| 2015 FY | 48.33 Million CNY | 383.39% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | 10 Million CNY | -94.95% |
| 2014 Q2 | 163 Million CNY | 0.0% |
| 2014 Q3 | 198 Million CNY | 21.47% |
| 2014 FY | 10 Million CNY | -87.34% |
| 2013 Q4 | 79 Million CNY | 0.0% |
| 2013 FY | 79 Million CNY | -20.84% |
| 2012 FY | 99.8 Million CNY | -6.86% |
| 2011 FY | 107.15 Million CNY | 94.82% |
| 2010 FY | 55 Million CNY | 0.0% |
| 2009 FY | - CNY | -100.0% |
| 2008 FY | 16 Million CNY | 0.0% |